Reduced Cholecystokinin Levels in the Limbic Lobe in Schizophrenia
- 1 July 1985
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 448 (1) , 495-506
- https://doi.org/10.1111/j.1749-6632.1985.tb29943.x
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patientsLife Sciences, 1985
- Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disordersLife Sciences, 1984
- Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaLife Sciences, 1983
- Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesionsLife Sciences, 1983
- CCK receptors and human neurological diseaseLife Sciences, 1982
- CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological studyBrain Research, 1981
- The regional distribution of somatostatin, substance P and neurotensin in human brainBrain Research, 1981
- Retention deficits after combined amygdalo-hippocampal and selective hippocampal resections in the monkeyNeuropsychologia, 1981
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- Peptidergic neuronesNature, 1980